Guangyu Liu

12PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2026
On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

|Jan 15, 2026
Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1.

Yun-Xiao Ling, Lisa Andriani, Shao-Ying Yang

|Nov 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.

Jun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng

|Jan 04, 2025
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST study.

Li Chen, Wen-Ya Wu, Fei Liang

|Apr 12, 2023
The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial.

Ying Zhang, Junjie Li, Miao Mo

|Dec 23, 2022
All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.

Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He

Pageof 2

Frequent Collaborators

2 joint publications

Zhi-Ming Shao

2 joint publications

Da-Qiang Li

2 joint publications

Si-Yu Wu

1 joint publications

Jin-Xiao Ren